重组HPV16 E6蛋白(His tag) (ab226447)
Key features and details
- Expression system: Escherichia coli
- Purity: > 90% SDS-PAGE
- Tags: His tag N-Terminus
- Suitable for: SDS-PAGE, MS
描述
-
产品名称
重组HPV16 E6蛋白(His tag) -
纯度
> 90 % SDS-PAGE. -
表达系统
Escherichia coli -
Accession
-
蛋白长度
Full length protein -
无动物成分
No -
性质
Recombinant -
-
序列
MHQKRTAMFQDPQERPRKLPQLCTELQTTIHDIILECVYCKQQLLRREVY DFAFRDLCIVYRDGNPYAVCDKCLKFYSKISEYRHYCYSLYGTTLEQQYN KPLCDLLIRCINCQKPLCPEEKQRHLDKKQRFHNIRGRWTGRCMSCCRSS RTRRETQL -
预测分子量
23 kDa including tags -
氨基酸
1 to 158 -
标签
His tag N-Terminus -
额外的序列信息
Human papillomavirus type 16
-
相关产品
-
Corresponding Antibody
技术指标
Our Abpromise guarantee covers the use of ab226447 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
应用
SDS-PAGE
Mass Spectrometry
-
质谱法
LC-MS/MS -
形式
Liquid -
Concentration information loading...
制备和贮存
-
稳定性和存储
Shipped at 4°C. Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
pH: 7.20
Constituents: Tris buffer, 50% Glycerol (glycerin, glycerine)
图片
-
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
-
Based on the SEQUEST from database of E.coli host and target protein, the LC-MS/MS Analysis result of ab226447 could indicate that this peptide derived from E.coli-expressed Homo sapiens (Human) E6.
-
Based on the SEQUEST from database of E.coli host and target protein, the LC-MS/MS Analysis result of ab226447 could indicate that this peptide derived from E.coli-expressed Homo sapiens (Human) E6.
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
文献 (2)
ab226447 被引用在 2 文献中.
- Chang YF et al. HPV16 E6 Promotes the Progression of HPV Infection-Associated Cervical Cancer by Upregulating Glucose-6-Phosphate Dehydrogenase Expression. Front Oncol 11:718781 (2021). PubMed: 34692493
- Rho SB et al. IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer. Int J Mol Sci 21:N/A (2020). PubMed: 33076322